The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFβ1, DNA damage and Fas

Carcinogenesis

Volumn 19, Issue 2, 1998, Pages 299-304

  Gill, Jason Harry ^a   James, Neil Haydn ^b   Roberts, Ruth Angela ^b   Dive, Caroline ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; FAS ANTIGEN; HYDROXYUREA; NAFENOPIN; PEROXISOME PROLIFERATOR; PROTEIN P21; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; LIVER CARCINOGENESIS; LIVER CELL; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; CARCINOGENS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FATTY ACID SYNTHETASE COMPLEX; MICE; NAFENOPIN; RATS; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031878863     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.2.299     Document Type: Article

References (45)

1. Ashby, J. and Tennant, R. (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res., 257, 229-306.
2. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidaemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol., 12, 1-58.
3. Moody, D.E., Reddy, J.K., Lake, B.G., Popp, J.A. and Reese, D.H. (1991) Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. Fund. Appl. Toxicol., 16, 233-248.
4. Reddy, J.K., Azarnoff, D.L. and Hignite, C.E. (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature, 283, 397-398.
5. Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650.
6. Green, S., Tugwood, J.D. and Issemann, I. (1992) The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessment. Toxicol. Lett., 64/65, 131-139.
7. Eacho, P.I., Lanier, T.L. and Brodhecker, C.A. (1991) Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of Wy-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis, 12, 1557-1561.
8. Melnick, R.L. (1992) Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J., 6, 2698-2706.
9. Schulte-Hermann, R., Hoffmann, V., Parzefall, W., Kallenbach, M., Gehardt, A. and Schuppler, J. (1980) Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers II. Induction of growth. Chem.-Biol. Interactions, 31, 287-300.
10. Oberhammer, F.A. and Roberts, R.A. (1994) Apoptosis: a widespread process involved in liver adaption and carcinogenesis. In Arias, I.M., Boyer, J.L., Fausto, N., Jakoby, W.B., Schachter, D.A. and Shafritz, D.A. (eds) The Liver: Biology and Pathobiology. Raven Press, New York, pp. 1547-1555.
11. Gill, J.H., Molloy, C.A., Shoesmith, K., Bayly, A.C. and Roberts, R.A. (1995) The rodent non-genotoxic hepatocarcinogen Nafenopin and EGF alter the mitosis/apoptosis balance promoting hepatoma cell clonal growth. Cell Death Diff., 2, 211-217.
12. Bursch, W., Lauer, B., Timmerman-Trosiener, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumour promoters. Carcinogenesis, 5, 453-458.
13. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H. and Wheeldon, E.B. (1995) Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis, 16, 1693-1698.
14. Bayly, A.C., Roberts, R.A. and Dive, C. (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell. Biol., 125, 197-203.
15. Roberts, R.A. (1996) Non-genotoxic hepatocarcinogenesis: Suppression of apoptosis by peroxisome proliferators. In Reddy, J.K., Suga, T., Mannaerts, G.P, Lazarow, P.B. and Subramani, S. (eds) Peroxisomes: Biology and Role in Toxicology and Disease. Annals of the New York Academy of Sciences, New York, pp. 588-611.
16. Watanabe-Fukunaga, R., Brannan, C.I., Itoh, N., Yonehara, S., Copeland, N.G., Jenkins, N.A. and Nagata, S. (1992) The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J. Immunol., 148, 1274-1279.
17. Nagata, S. (1996) Apoptosis: telling cells their time is up. Curr. Biol., 6, 1241-1243.
18. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. and Nagata, S. (1993) Lethal effect of the anti-Fas antibody in mice. Nature, 364, 806-809.
19. Ni, R., Tomita, Y. Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J. and Nagata, S. (1994) Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res., 215, 332-337.
20. Green, S. (1991) The search for molecular mechanisms of non-genotoxic carcinogens. Mutat. Res., 248, 371-374.
21. Richardson, F.C., Dyroff, M.C., Boucheron, J.A. and Swenberg, J.A. (1985) Differential repair of O4-alkylthymidine following exposure to methylating and ethylating hepatocarcinogens. Carcinogenesis, 6, 625-629.
22. Kraupp-Grasl, B., Huber, W., Putz, B., Gerbracht, U. and Schulte-Hermann, R. (1990) Tumour promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res., 50, 3701-3708.
23. Chen, G.L., Yang, L., Rowe, T.C. Halligan, B.D., Tewey, K.M. and Liu, L.F. (1984) Non-intercalative antitumour drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem., 259, 13560-13566.
24. Walker, P.R., Smith, C., Youdale, T., Leblanc, J., Whitfield, J.F. and Sikorska, M. (1991) Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res., 51, 1078-1085.
25. Seglen, P.O. (1973) Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp. Cell Res., 82, 391-398.
26. James, N.H and Roberts, R.A (1996) Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis, 17, 1623-1632.
27. Laemmli, U.K. and Favre, M. (1973) Mutation of the head of bacteriophage T4.1. DNA packaging events. J. Mol. Biol., 80, 575-599.
28. Cary, N.C. (1989) SAS/STAT User's Guide. SAS Institute Inc., Cary.
29. Oberhammer, F.A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A.F., Bursch, W. and Schulte-Hermann, R. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β-1. PNAS, 89, 5408-5412.
30. James, N.H. and Roberts, R.A. (1995) Species differences in the clonal expansion of hepatocytes in response to the coaction of epidermal growth factor and nafenopin, a rodent hepatocarcinogenic peroxisome proliferator. Fund. Appl. Toxicol., 26, 143-149.
31. Stemmermann, G.N., Ames, B.N., Swirsky Gold, L., Cohen, S.M., Ellwein, L.B., Butterworth, B.E. and Farber, E. (1996) Correspondence re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 56, 4267-4274.
32. Haffner, R. and Oren, M. (1995) Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev., 5, 84-90.
33. Bates, S. and Vousden, K.H. (1996) p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6, 12-19.
34. Midgley, C.A., Owens, B., Briscoe, C.V., Thomas, D.B., Lane, D.P. and Hall, P.A. (1995) Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci., 108, 1843-1848.
35. Bellamy, C.O.C., Clarke, A.R., Wyllie, A.H. and Harrison, D.J. (1997) p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J., 11, 591-599.
36. Richburg, J.H., Lee, J. and Boekelheide, K. (1997) Phthalate-induced alterations in testicular germ cell apoptosis. Fund. Appl. Toxicol., 36, 286.
37. Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P.H. and Peter, M.E. (1995) Cytotoxicity-dependent APO-1 (Fas/ CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J., 14, 5579-5588.
38. Muzio, M., Chinnaiyan, A.M, Kischkel, F.C., et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85, 817-827.
39. Barinaga, M. (1996) Forging a path to cell death. Science, 273, 735-737.
40. Rouquet, N., Carlier, K., Briand, P., Wiels, J. and Joulin, V. (1996) Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem. Biophys. Res. Commun., 229, 27-35.
41. Inayat-Hussain, S.H., Couet, C., Cohen, G.M. and Cain, K. (1996) TGF-β1 induced apoptosis in hepatocytes involves activation of interleukin-1β-converting enzyme like protease(s). Biochem. Soc. Trans., 24, Abstract.
42. Jones, N.A., Turner, J., Mc Ilwrath, A.J., Brown, R. and Dive, C. (1998) p53 dependent and p53 independent up regulation of Bak and Bax during cisplatin and taxol induced apoptosis of ovarian carcinoma cells. Mol. Pharm. (in press).
43. Green, S. (1992) Receptor-mediated mechanisms of peroxisome proliferators. Biochem. Pharm., 43, 393-401.
44. Roberts, R.A., James, N.H., Woodyat, N.J., Macdonald, N. and Tugwood, J.D. (1998) Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPARα). Carcinogenesis, 19, 43-48.
45. Reed, J.C. (1997) Double identity for proteins of the Bcl-2 family. Nature, 387, 773-776.